Heavy Periods in Perimenopause: Causes and Treatments

Heavy periods can happen during perimenopause. Bleeding that takes over your life still deserves investigation—and you do not have to wait for menopause to get treatment.

You start carrying an extra pad and wearing dark trousers on the days your period is heaviest. Over time, you may find yourself planning around bathrooms and deciding how long you can safely be away from home. That change in what you can do is useful information when you ask for help.

Ovulation often changes in perimenopause and may account for some heavy bleeding. Fibroids, polyps, adenomyosis, medications and changes in the uterine lining can produce similar symptoms, and sometimes more than one factor is involved. An assessment can help establish what you are losing and which treatments are likely to make daily life easier.

IN THIS ARTICLE

What counts as a heavy period?
Why perimenopause can change bleeding—and why that is not the whole diagnosis
When does bleeding need a biopsy?
What a useful assessment includes
Your hemoglobin can be normal while your iron stores are low
Which treatments can reduce heavy bleeding?
When medicines are not enough
Bring a short record—and ask for a plan
Sources and review notes

What counts as a heavy period?

The practical definition is bleeding that interferes with your physical, social, emotional or material quality of life. You do not need to collect blood in a measuring cup to qualify for care. Flooding through protection, getting up repeatedly at night to change it, passing large clots, bleeding for longer than your usual period, or cancelling activities because you cannot manage the flow are useful things to describe. The effect on your life belongs in the medical history, not in an apologetic sentence at the end of the appointment.

It also helps to separate heavy from irregular. A cycle can be irregular without much blood loss, or fairly predictable but very heavy. Bleeding between periods and bleeding after sex deserve their own mention. An app’s reassurance that irregularity is common cannot assess those patterns.

Why perimenopause can change bleeding—and why that is not the whole diagnosis

As ovulation becomes less consistent, the usual sequence of estrogen and progesterone changes becomes less predictable. The uterine lining may build up and shed unevenly, sometimes after a long gap between periods. That can explain an unexpectedly prolonged or heavy bleed, but it cannot establish that hormones are the only explanation. A fibroid projecting into the uterine cavity, for example, may matter more for bleeding than a larger fibroid elsewhere.

Polyps arise from the lining; adenomyosis involves endometrial-type tissue within the uterine muscle and can cause heavy, painful periods. Bleeding disorders, thyroid disease in the appropriate clinical setting, anticoagulants and other medicines may also be relevant. Pregnancy remains possible during perimenopause. Hyperplasia and endometrial cancer are less common explanations, but important ones to consider when the pattern and risk factors call for investigation. Most heavy periods are not cancer; assessing them is how clinicians avoid simply assuming that they are benign.

When does bleeding need a biopsy?

There is no single age rule that replaces a clinical assessment. The reaffirmed SOGC abnormal-bleeding guideline advises considering endometrial biopsy in bleeding women over 40, in younger women with endometrial-cancer risk factors, and when bleeding does not respond to treatment. Ontario Health’s 2024 quality standard likewise uses a risk-based approach that includes age over 40 among its risk factors. US guidance often uses age over 45 as a first-line sampling threshold. That is why an article quoting only “45 and older” can give Canadian readers an incomplete picture.

Other reasons to consider sampling include persistent bleeding between periods, chronic anovulation or PCOS, obesity, diabetes, prolonged unopposed estrogen exposure, tamoxifen use and a relevant family history. A biopsy recommendation does not mean that cancer has been diagnosed. It means that tissue information may change what happens next.

The procedure offered may differ between services. Canadian pathways commonly use office sampling when appropriate; NICE recommends biopsy in the context of hysteroscopy for women at high risk of endometrial pathology. Hysteroscopy lets a clinician look inside the cavity and target a suspected polyp or other focal abnormality. Ask what question the proposed test will answer and what the plan is if the sample is insufficient or bleeding continues. Our endometrial-biopsy guide also covers limitations and the importance of discussing pain relief, consent and alternatives beforehand.

What a useful assessment includes

A clinician should ask about the timing and duration of bleeding, flooding, pain, pregnancy possibility, medications, previous procedures and how you are managing day to day. Examination can help establish where the blood is coming from and whether there are signs of a structural problem. A complete blood count checks for anemia; a pregnancy test is appropriate if pregnancy is possible. Thyroid and clotting investigations are guided by the history rather than added automatically to every hormone panel.

Ultrasound is useful when fibroids, adenomyosis or other structural changes are suspected, or treatment has not helped. It does not answer every question about the lining. Endometrial thickness varies across menstruating cycles, so the postmenopausal “thin lining” rule cannot simply be applied to a perimenopausal scan. A reassuring ultrasound or a normal cervical-screening result does not necessarily remove the need for endometrial sampling. Persistent symptoms need a follow-up plan, even after an initially reassuring test.

Your hemoglobin can be normal while your iron stores are low

Iron deficiency can develop before anemia appears on a blood count. Fatigue, reduced exercise tolerance, restless legs or difficulty concentrating may accompany it, although these symptoms have other causes too. In someone with substantial menstrual blood loss or suggestive symptoms, ferritin can help assess iron stores. BC’s iron-deficiency guideline supports testing people at risk; NICE does not recommend routine ferritin for every person with heavy menstrual bleeding. Those positions do not make a normal hemoglobin proof that your iron stores are adequate.

If deficiency is confirmed, the plan should address both iron replacement and ongoing blood loss. Oral iron is often tried first; intolerance, inadequate response or substantial continuing loss may make intravenous treatment appropriate. The preparation, amount and follow-up should be individualized. Taking more iron indefinitely without reviewing the bleeding is not a complete solution. Our fatigue guide explains why exhaustion deserves assessment beyond a menopause label.

Which treatments can reduce heavy bleeding?

You can often discuss treatment while investigations are being arranged; whether it is safe to start immediately depends on the bleeding, examination, pregnancy possibility and suspected cause. Ontario Health recommends offering both hormonal and nonhormonal options. Your preference matters: someone who needs contraception may choose differently from someone trying to conceive, avoiding hormones or seeking relief from painful periods as well as blood loss.

Tranexamic acid: an option used on bleeding days

Tranexamic acid reduces the breakdown of blood clots and can reduce menstrual blood loss without being a hormone or contraceptive. Canadian prescription products include Cyklokapron. It is used during heavy bleeding according to the prescription, not as an indefinitely continuous daily medicine. It will not remove a fibroid or establish why bleeding has changed.

The safety review matters. A history of thrombosis or important clotting risk, active thromboembolic disease, kidney impairment and blood in the urine can affect suitability; kidney impairment may require a different regimen. The Canadian monograph also warns about added thrombotic risk with hormonal contraceptives. Do not combine it with an estrogen-containing pill, patch or contraceptive ring on your own, borrow another person’s prescription, or substitute a US internet dose. Ask the prescriber or pharmacist to check your actual medicines and history.

Anti-inflammatory medicines: sometimes useful for flow and pain

NSAIDs such as ibuprofen or naproxen can help period pain and reduce blood loss for some people. They are not interchangeable with aspirin, which can increase bleeding. Stomach ulcers or gastrointestinal bleeding, kidney disease, cardiovascular conditions, anticoagulants and some bleeding disorders may make an NSAID unsuitable. Avoid combining different NSAIDs, and follow advice about dose and duration. A familiar over-the-counter package is still a medicine with risks.

A hormonal IUD: effective bleeding control, with some settling-in time

A 52 mg levonorgestrel intrauterine system can markedly reduce heavy periods when the uterine cavity and medical history make it appropriate. The Canadian Mirena monograph authorizes treatment of idiopathic menorrhagia, after appropriate investigation, for up to five years. Its contraceptive authorization extends to eight years. Those are different indications and durations. Lower-dose devices should not be assumed to provide the same heavy-bleeding treatment.

Spotting or irregular bleeding is common during the early months, and benefit takes time. Ask what to expect, when bleeding should be reassessed, and what pain-management options are available for insertion. Whether an IUD can also provide endometrial protection with systemic estrogen is a separate prescribing question; its eight-year contraceptive lifespan is not a promise of eight-year HRT protection.

Other hormonal choices

Combined hormonal contraception can regulate bleeding and prevent pregnancy for appropriately selected people. Migraine with aura, smoking, blood pressure and clotting or vascular history are important parts of that decision. Progestogen-only treatment may be an alternative. The route and schedule should be chosen for the diagnosis and your priorities, rather than assuming that any progesterone product will do the same job.

Standard menopausal hormone therapy is not contraception and is not automatically the best treatment for substantial heavy menstrual bleeding. If bleeding changes while you use HRT, describe the precise preparation and schedule to your clinician. Do not independently remove prescribed endometrial protection while continuing systemic estrogen. Our Canadian MHT guide explains that distinction.

When medicines are not enough

The next option depends on the cause. Hysteroscopy can remove a polyp or selected fibroids inside the cavity. Other fibroid procedures include myomectomy or uterine artery embolization, with different implications for recovery and future pregnancy. Endometrial ablation destroys the lining and may reduce bleeding when childbearing is complete, but is not appropriate for every uterus or diagnosis. It is not contraception: pregnancy afterwards can be dangerous, and reliable pregnancy prevention remains necessary while pregnancy is possible. Assessment of the lining belongs before an ablation, and future bleeding may be harder to investigate afterwards.

Hysterectomy definitively ends uterine bleeding but involves major surgery, recovery and potential complications. It does not automatically mean removing the ovaries or immediately entering surgical menopause. Ask which organs would be removed, what alternatives remain, and how each option fits your symptoms, anatomy and preferences. The decision should not be reduced to “put up with it or have everything out.”

Bring a short record—and ask for a plan

Record bleeding dates, flooding or frequent product changes, pain, clots, bleeding between periods or after sex, and the effect on work, sleep and ordinary activities. The existing 14-day symptom tracker can hold a useful snapshot; add a brief cycle history if bleeding spans longer than two weeks. There is no need for another form, and tracking must never delay urgent care.

A useful closing question is: “What are we doing to reduce the bleeding, what are we investigating, and when should I contact you if it continues?” Ask who will communicate results and what happens if treatment does not suit you. You deserve more than an explanation for why your periods are difficult. You deserve a workable next step.

Already past menopause? Bleeding after 12 months without a natural period needs assessment, even if it is light. Hormonal treatment can make the pattern harder to interpret, but it does not make unexplained bleeding safe to ignore. Use our separate postmenopausal-bleeding assessment guide.

Sources and review notes

Clinical guidance and Canadian product information checked November 6, 2026. This is educational information, not a diagnosis or an individualized prescription.